S-6472

Known as: S 6472, S6472 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-1990
051019851990

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Clinical studies on S 6472, a longer lasting preparation of cefaclor (CCL), were performed and the following results were… (More)
Is this relevant?
1990
1990
We conducted a clinical investigation on the use of S6472, an sustained release preparation of cefaclor, in the dermatological… (More)
Is this relevant?
1988
1988
Clinical evaluation of S 6472 (sustained release preparations of cefaclor), a granule form of cefaclor, was performed in 20… (More)
Is this relevant?
1986
1986
The S6472 is a 4:6 mixture of 2 types of granules of cefaclor (CCL) coated with different films; one type of granules is soluble… (More)
Is this relevant?
1985
1985
Fundamental and clinical studies on S 6472 were carried out and following results were obtained. Serum concentrations after… (More)
Is this relevant?
1985
1985
A study in which 375 mg of S6472 was orally given to 3 healthy adult volunteers before a meal, after a light meal, and after a… (More)
Is this relevant?
1985
1985
In order to see absorption and excretion of S6472 (sustained release preparations of cefaclor (CCL], 3 studies regarding, 1… (More)
Is this relevant?
1985
1985
Fundamental and clinical studies of S6472 (sustained release preparation of cefaclor (CCL] were conducted in the surgical field… (More)
Is this relevant?
1985
1985
Current (regular) preparation of cefaclor (CCL) require the 3-time-a-day administration. S6472 (sustained release preparation… (More)
Is this relevant?
1985
1985
A double-blind comparative study of S6472 and cefaclor (CCL) was conducted to evaluate the therapeutic efficacy, safety and… (More)
Is this relevant?